Stock Movers

iHeartPodcasts
  • 0.0 (0)
  • Business News
  • Updated daily

Listen for five-minute conversations on today's biggest winners and losers in the stock market.  Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.

  1. 24 min ago

    Qualcomm Soars, Boston Scientific Falls, Constellation Brands Declines

    Today's biggest winners and losers in the stock market, a look at the notable movers: On this episode of Stock Movers:- Qualcomm (QCOM) signed an agreement with Amazon.com Inc. to create customized chips for Amazon Web Services' AI infrastructure. The agreement gives Amazon the right to acquire as much as $4 billion in Qualcomm stock and will last through "multiple generations" of equipment. Qualcomm will start to book revenue from Amazon in its fiscal first quarter and has expressed confidence that it will achieve a $5 billion data center revenue target for fiscal 2027. Qualcomm investors applauded the agreement, sending the shares up as much as 8.7% to $183.49 in New York. It was their biggest intraday gain since June 25.- Boston Scientific (BSX) and Stryker (SYK) shares fell after the companies said they are dealing with the repercussions of separate cyber attacks. The cyber attacks curtailed the companies' ability to get products to customers and dented sales, with damage that could last for months. Both companies sell medical devices and are working to recover from the cyber incidents, with Boston Scientific's full operational recovery timeline remaining uncertain. Boston Scientific fell as much as 4.9% Tuesday in New York, while Stryker was down as much as 9.1%.- Constellation Brands (STZ) shares are down as much as 3.7%, to the lowest intraday since April 2020, as CEO Nick Fink and EVP/CFO Garth Hankinson speak at the Barclays consumer conference. See omnystudio.com/listener for privacy information.

  2. 4 hr ago

    Amgen Tumbles, Oracle Rises, Bloom Energy Gains on Upside From S&P 500 Inclusion

    On this episode of Stock Movers: Amgen (AMGN) shares tumble. Shares of makers of heart drugs like Ionis Pharmaceuticals and Amgen are lower after Novartis AG said its heart medication, pelacarsen, failed in a final-stage study. Oracle (ORCL) shares gain. Analysts are growing optimistic about the software company’s upcoming results, due after the market close on Thursday. The stock is on track for a fourth straight positive session, and has gained 19% over that stretch. Bloom Energy (BE) shares gain. Bloom Energy and Everpure shares are rising on Tuesday after S&P Dow Jones Indices said the companies will join the S&P 500 Index, effective prior to the open of trading on Sept. 21.  See omnystudio.com/listener for privacy information.

  3. 5 hr ago

    SpaceX Rises, Qualcomm Gains, Roivant Climbs After Lung Drug Study Meets Main Goal

    On this episode of Stock Movers: - SpaceX (SPCX) shares rise. SpaceX's weighting in the Nasdaq 100 Index is expected to rise after the index's next rebalancing, which is set to be announced on Friday and take effect on Sept. 21. The increase in weighting could force $12.4 billion of net passive buying from index funds and ETFs, according to revised estimates by JPMorgan Securities strategists. - Qualcomm (QCOM) shares gain. Qualcomm Inc. said it signed up Amazon.com Inc. as a data center chip customer in a deal that will span "multiple generations" and gives Amazon the right to acquire as much as $4 billion in shares. The tie-up will create customized silicon to support Amazon Web Services artificial intelligence infrastructure, with the two working on chips that run AI services and others that connect computer components. - Roivant (ROIV) shares climb. The drugmaker said a mid-stage study of its inhaled drug, mosliciguat, met its primary endpoint in the treatment for a lung disease. See omnystudio.com/listener for privacy information.

  4. 6 hr ago

    Novartis and Boston Scientific Slide; Intel Price Hikes

    Today's biggest winners and losers in the stock market. On this episode of Stock Movers: - Novartis (NOVN) shares are lower as it suffered its third clinical-trial setback in a week after a treatment for a rare muscle-wasting disease failed a late-stage study. - Boston Scientific (BSX) shares are moving on news it said that fallout from a cybersecurity incident has impacted its ability to ship its products to customers and will cause the medical devices company to miss its sales growth and earnings estimates for the year.  - Intel (INTC) is rising on a report that the company could raise computer chip prices next month. See omnystudio.com/listener for privacy information.

  5. 8 hr ago

    Novartis Drop; Boston Scientific Cyberattack; Intel Rises

    Today's biggest winners and losers in the stock market. On this episode of Stock Movers:- Novartis (NOVN) shares are lower as it suffered its third clinical-trial setback in a week after a treatment for a rare muscle-wasting disease failed a late-stage study. - Boston Scientific (BSX) shares are moving on news it said that fallout from a cybersecurity incident has impacted its ability to ship its products to customers and will cause the medical devices company to miss its sales growth and earnings estimates for the year. - Intel (INTC) is rising on a report that the company could raise computer chip prices next month. See omnystudio.com/listener for privacy information.

  6. 10 hr ago

    Novartis Slumps, Rubis Gains, Computacenter Up

    Today's biggest winners and losers in the stock market.On this episode of Stock Movers:- Novartis suffered its third clinical-trial setback in a week after a treatment for a rare muscle-wasting disease failed a late-stage study. Novartis shares plunged as much as 10% in early Zurich trading, reducing their gain for the year to about 4%, trailing rival Roche. - Computacenter shares climb as much as 7.4%, reaching a record high, after the IT services company upgraded its profit before tax guidance for fiscal year 2026 once again, after doing so at its July trading update. The group also reported a revenue beat in the first half, driven by strong AI-related spend in the US. - Rubis shares rise as much as 5.3% after the energy solutions firm boosted its Ebitda guidance for the full year. See omnystudio.com/listener for privacy information.

  7. 11 hr ago

    Novartis Slumps, Sandoz Gains, Computacenter Up

    Today's biggest winners and losers in the stock market.On this episode of Stock Movers:- Novartis suffered its third clinical-trial setback in a week after a treatment for a rare muscle-wasting disease failed a late-stage study. Novartis shares plunged as much as 10% in early Zurich trading, reducing their gain for the year to about 4%, trailing rival Roche. - Sandoz nudged up its mid-term guidance and set a goal of increasing the number of biosimilars in its portfolio to more than 100 by 2040, from 13 currently.- Computacenter shares climb as much as 7.4%, reaching a record high, after the IT services company upgraded its profit before tax guidance for fiscal year 2026 once again, after doing so at its July trading update. The group also reported a revenue beat in the first half, driven by strong AI-related spend in the US. See omnystudio.com/listener for privacy information.

  8. 13 hr ago

    Samsung Gains, Asia PC Drops, Insilico Jumps

    Today's biggest winners and losers in the stock market.On this episode of Stock Movers:- Samsung's anticipated equity buyback is raising investor expectations that the Korean giant will buy up non‑voting preferred shares, narrowing a steep discount and setting an example for others. - Asia PC maker shares drop after a report that Intel plans to raise personal computer CPU prices by another 10% as early as next month.- An experimental lung disease drug developed using artificial intelligence showed promise in reversing biological signs of ageing, pointing to broader potential use of the treatment, according to its developer. Insilico’s shares jumped as much as 10% on Tuesday, the most since August 25th. See omnystudio.com/listener for privacy information.

See All (2k)

Hosts & Guests

About

Listen for five-minute conversations on today's biggest winners and losers in the stock market.  Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.

Information

  • Creator
    iHeartPodcasts
  • Years Active
    2025 - 2026
  • Episodes
    2k
  • Rating
    Clean
  • Copyright
    2026 iHeartMedia, Inc. © Any use of this intellectual property for text and data mining or computational analysis including as training material for artificial intelligence systems is strictly prohibited without express written consent from iHeartMedia
  • Show Website
    Stock Movers

You Might Also Like